9 results on '"Myllynen, P."'
Search Results
2. Benzo(a)pyrene increases phosphorylation of p53 at serine 392 in relation to p53 induction and cell death in MCF-7 cells
- Author
-
Tampio, M., primary, Loikkanen, J., additional, Myllynen, P., additional, Mertanen, A., additional, and Vähäkangas, K.H., additional
- Published
- 2008
- Full Text
- View/download PDF
3. DNA damage caused by benzo(a)pyrene in MCF-7 cells is increased by verapamil, probenecid and PSC833
- Author
-
MYLLYNEN, P, primary, KURTTILA, T, additional, VASKIVUO, L, additional, and VAHAKANGAS, K, additional
- Published
- 2007
- Full Text
- View/download PDF
4. 417 Cigarette smoking and p53 expression in the placental tissue
- Author
-
Myllynen, P., Pienimäki, P., and Vähäkangas, K.
- Published
- 2003
- Full Text
- View/download PDF
5. Activities of metabolizing enzymes in human placenta.
- Author
-
Mohammed AM, Huuskonen P, Juvonen R, Sahlman H, Repo J, Myöhänen K, Myllynen P, Woo CJ, Karttunen V, and Vähäkangas K
- Subjects
- Adult, Female, Humans, Pregnancy, Antipyrine metabolism, Aromatase metabolism, Catalase metabolism, Cytochrome P-450 CYP1A1 metabolism, Glucuronosyltransferase metabolism, Glutathione Transferase metabolism, Placenta metabolism
- Abstract
In addition to the transfer across the placenta, placenta displays hormonal and xenobiotic metabolism, as well as enzymatic defense against oxidative stress. We analyzed aromatase (CYP19A1), uridine 5'-diphospho-glucuronyltransferase (UGT), glutathione-S-transferase (GST) and catalase (CAT) activities in over 70 placentas from nonsmokers stored at -80 °C from former perfusion studies. A wide interindividual variation in all activities was found. Longterm storage at -80 °C did not affect the activities. Ethoxyresorufin-O-deethylase (EROD, CYP1A1) was not detected in any of the studied placentas perfused with chemicals. Several compounds in placental perfusion changed statistically significantly the enzyme activities in placental tissue. Melamine and nicotine increased CYP19A1, melamine increased UGT and GST, PhIP with ethanol decreased CYP19A1 and increased GST, and PhIP with buprenorphine decreased CAT. Antipyrine in 100 μg/ml also changed the studied enzyme activities, but not statistically significantly. Because antipyrine is a reference compound in placental perfusions, its potential effects must be taken into account in human placental perfusion. Enzyme activities deserve further studies as biomarkers of placental toxicity. Finally, enzyme activities deserve further studies as biomarkers of placental toxicity., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2020. Published by Elsevier B.V.)
- Published
- 2020
- Full Text
- View/download PDF
6. The effects of aflatoxin B1 on transporters and steroid metabolizing enzymes in JEG-3 cells.
- Author
-
Huuskonen P, Myllynen P, Storvik M, and Pasanen M
- Subjects
- ATP Binding Cassette Transporter, Subfamily B drug effects, ATP Binding Cassette Transporter, Subfamily B metabolism, ATP Binding Cassette Transporter, Subfamily B, Member 1 drug effects, ATP Binding Cassette Transporter, Subfamily B, Member 1 metabolism, ATP Binding Cassette Transporter, Subfamily G, Member 2, ATP-Binding Cassette Transporters genetics, ATP-Binding Cassette Transporters metabolism, Aromatase metabolism, Cell Line, Tumor, Choriocarcinoma genetics, Cytochrome P-450 CYP1A1 metabolism, Dose-Response Relationship, Drug, Enzymes genetics, Estradiol Dehydrogenases metabolism, Gene Expression Regulation, Enzymologic, Glucuronosyltransferase metabolism, Humans, Multidrug Resistance-Associated Protein 2, Multidrug Resistance-Associated Proteins drug effects, Multidrug Resistance-Associated Proteins metabolism, Multienzyme Complexes metabolism, Neoplasm Proteins drug effects, Neoplasm Proteins metabolism, Organic Anion Transporters, Sodium-Independent genetics, Organic Anion Transporters, Sodium-Independent metabolism, Progesterone Reductase metabolism, RNA, Messenger metabolism, Steroid Isomerases metabolism, Time Factors, ATP-Binding Cassette Transporters drug effects, Aflatoxin B1 pharmacology, Choriocarcinoma enzymology, Enzymes metabolism, Organic Anion Transporters, Sodium-Independent drug effects, Steroids biosynthesis
- Abstract
Effects of 96 h aflatoxin B1 (AFB1) exposure at concentrations from 0.2 μM to 6 μM on the mRNA and protein expression levels of the following transporters ABCB1/B4, ABCC1, ABCC2, ABCG2, OAT4 and the mRNA expression of steroid-metabolizing enzymes CYP1A1, CYP19A1, HSD3B1 and HSD17B1, and conjugating enzyme family UGT1A were evaluated in trophoblastic JEG-3 cells. Statistically significant dose-dependent five-fold increases in the expression levels with ABCC2 and OAT4 were recorded at 2 and 6μM AFB1. Protein expression of ABCG2 was decreased dose-dependently with 0.2-6 μM AFB1. With the other transporters, only a trend of increased expression was observed. Analogously, a three-fold increase in the expressions of CYP19A1, HSD3B1, HSD17B1 and UGT1A-family were observed at 0.3 μM AFB1. When an inhibitor of CYP19A1, finrozole, was dosed simultaneously with AFB1, no increases in the transcripts of transporters or steroid hydroxylases or CYP19A1 were observed. This delayed increase in the expression levels - only after 96h incubations - may indicate that the response is due to a secondary metabolite of AFB1 or other secondary controlling cascades rather than the parent compound itself. In conclusion, AFB1 affected the placental steroid synthesizing, metabolizing and conjugating enzymes as well as the expression levels of several transporter proteins in JEG-3 cells. These alterations may lead to anomalies in the foetoplacental hormonal homeostasis., (Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
7. Fate of the teratogenic and carcinogenic ochratoxin A in human perfused placenta.
- Author
-
Woo CS, Partanen H, Myllynen P, Vähäkangas K, and El-Nezami H
- Subjects
- ATP Binding Cassette Transporter, Subfamily G, Member 2, ATP-Binding Cassette Transporters metabolism, Albumins metabolism, Carrier Proteins metabolism, Cell Line, Female, Humans, In Vitro Techniques, Maternal-Fetal Exchange, Multidrug Resistance-Associated Protein 2, Multidrug Resistance-Associated Proteins metabolism, Neoplasm Proteins metabolism, Organic Anion Transporters, Sodium-Independent metabolism, Perfusion, Pregnancy, Carcinogens pharmacokinetics, Ochratoxins pharmacokinetics, Placenta metabolism, Teratogens pharmacokinetics
- Abstract
Ochratoxin A (OTA) is one of the most frequent mycotoxins detected in human blood worldwide. Apart from its well known nephrotoxicity, OTA-induced teratogenicity and carcinogenicity proven in animals are potential effects also in humans. Pregnant women have been exposed to this food contaminant via dietary exposure in a continuous and widespread manner. Although the transplacental transfer of OTA has been demonstrated in laboratory animals and the presence of OTA in human fetal samples has been reported, little is known about the role of human placenta in OTA toxicokinetics. In this study, human perfused placenta was used to reveal the actual placental toxicokinetics of OTA using concentrations found in serum of pregnant women. Moreover, the effect of protein concentration and biological significance of placental transporters on the OTA transfer in human placenta were also determined. Our study is the first to pursue the transfer of OTA through perfused human placenta. The transfer of OTA through term human placenta was barely detectable in all perfusions. Inhibitors of neither ABCG2 nor ABCC2 increased the transport of OTA to fetal circulation in placental perfusion, and thus these transporters apparently do not have biological significance in inhibiting transplacental transfer of OTA. Human albumin has inhibited OTA transfer through a tight monolayer of BeWo b30 cells. Finding from this study clearly contradict the existing epidemiological studies reporting higher OTA levels in fetal than in maternal circulation in vivo., (Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
8. Acute effects of ethanol on the transfer of nicotine and two dietary carcinogens in human placental perfusion.
- Author
-
Veid J, Karttunen V, Myöhänen K, Myllynen P, Auriola S, Halonen T, and Vähäkangas K
- Subjects
- ATP Binding Cassette Transporter, Subfamily G, Member 2, ATP-Binding Cassette Transporters antagonists & inhibitors, ATP-Binding Cassette Transporters metabolism, Adenocarcinoma metabolism, Antipyrine chemistry, Biological Transport drug effects, Breast Neoplasms metabolism, Carbon Radioisotopes, Carcinogens chemistry, Cell Line, Tumor, Diffusion, Dimethylnitrosamine metabolism, Female, Food Contamination, Humans, Imidazoles metabolism, In Vitro Techniques, Indicators and Reagents chemistry, Kinetics, Neoplasm Proteins antagonists & inhibitors, Neoplasm Proteins metabolism, Nicotine chemistry, Perfusion, Placenta metabolism, Pregnancy, Carcinogens metabolism, Ethanol pharmacology, Nicotine metabolism, Placenta drug effects
- Abstract
Many mothers use, against instructions, alcohol during pregnancy. Simultaneously mothers are exposed to a wide range of other environmental chemicals. These chemicals may also harm the developing fetus, because almost all toxic compounds can go through human placenta. Toxicokinetic effects of ethanol on the transfer of other environmental compounds through human placenta have not been studied before. It is known that ethanol has lytic properties and increases the permeability and fluidity of cell membranes. We studied the effects of ethanol on the transfer of three different environmental toxins: nicotine, PhIP (2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine) and NDMA (N-nitrosodimethylamine) in placental perfusion. We tested in human breast cancer adenocarcinoma cell line MCF-7 whether ethanol affects ABCG2/BCRP, which is also the major transporter in human placenta. We found that the transfer of ethanol is comparable to that of antipyrine, which points to passive diffusion as the transfer mechanism. Unexpectedly, ethanol had no statistically significant effect on the transfer of the other studied compounds. Neither did ethanol inhibit the function of ABCG2/BCRP. These experiments represent only the effects of acute exposure to ethanol and chronic exposure remains to be studied., (Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
9. Placental transfer and DNA binding of benzo(a)pyrene in human placental perfusion.
- Author
-
Karttunen V, Myllynen P, Prochazka G, Pelkonen O, Segerbäck D, and Vähäkangas K
- Subjects
- Cell Line, Tumor, Choriocarcinoma metabolism, Cytochrome P-450 CYP1A1 metabolism, DNA Adducts, Dose-Response Relationship, Drug, Female, Humans, Perfusion, Placenta enzymology, Placenta physiology, Pregnancy, Time Factors, Benzo(a)pyrene chemistry, DNA chemistry, Maternal-Fetal Exchange physiology, Placenta drug effects
- Abstract
Benzo(a)pyrene (BP) is the best studied polycyclic aromatic hydrocarbon, classified as carcinogenic to humans. The carcinogenic metabolite, benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide (BPDE), binds covalently to DNA. The key enzyme in this metabolic reaction is CYP1A1, which has also been found in placenta and human trophoblastic cells. By using human placental perfusion we confirmed that BP added to the maternal circulation in concentrations of 0.1 and 1 microM reaches fetal compartment but somewhat slower than the freely diffusible reference substance antipyrine. A well-known P-glycoprotein (ABCB1/P-gp) antagonist verapamil did not affect the transfer more than it did in the case of antipyrine, indicating that ABCB1/P-gp does not have a role in BP transfer. In one of the two placentas perfused for 6 h with the higher concentration of BP (1 microM) BPDE specific DNA adducts were found in placental tissue after the perfusion, but not before. The ability of human trophoblastic cells to activate BP to BPDE-DNA adducts was confirmed in human trophoblastic BeWo cells. This study shows that maternal exposure to BP leads to the exposure of the fetus to BP and/or its metabolites and that placenta itself can activate BP to DNA adducts., (Copyright 2010 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.